Intervention Review

You have free access to this content

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

  1. Suetonia C Palmer1,
  2. Sankar D Navaneethan2,
  3. Jonathan C Craig3,4,
  4. David W Johnson5,
  5. Vlado Perkovic6,
  6. Jorgen Hegbrant7,
  7. Giovanni FM Strippoli3,4,8,9,10,11,*

Editorial Group: Cochrane Kidney and Transplant Group

Published Online: 31 MAY 2014

Assessed as up-to-date: 5 JUN 2012

DOI: 10.1002/14651858.CD007784.pub2


How to Cite

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GFM. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD007784. DOI: 10.1002/14651858.CD007784.pub2.

Author Information

  1. 1

    University of Otago Christchurch, Department of Medicine, Christchurch, New Zealand

  2. 2

    Glickman Urological and Kidney Institute, Cleveland Clinic, Department of Nephrology and Hypertension, Cleveland, OH, USA

  3. 3

    The University of Sydney, Sydney School of Public Health, Sydney, NSW, Australia

  4. 4

    The Children's Hospital at Westmead, Cochrane Renal Group, Centre for Kidney Research, Westmead, NSW, Australia

  5. 5

    Princess Alexandra Hospital, Department of Nephrology, Woolloongabba, Queensland, Australia

  6. 6

    The George Institute for Global Health, Renal and Metabolic Division, Camperdown, NSW, Australia

  7. 7

    Diaverum Renal Services Group, Medical Office, Lund, Sweden

  8. 8

    University of Bari, Department of Emergency and Organ Transplantation, Bari, Italy

  9. 9

    Mario Negri Sud Consortium, Department of Clinical Pharmacology and Epidemiology, Santa Maria Imbaro, Italy

  10. 10

    Diaverum, Medical-Scientific Office, Lund, Sweden

  11. 11

    Amedeo Avogadro University of Eastern Piedmont, Division of Nephrology and Transplantation, Department of Translational Medicine, Novara, Italy

*Giovanni FM Strippoli, Cochrane Renal Group, Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia. strippoli@negrisud.it. gfmstrippoli@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 31 MAY 2014

SEARCH

  1. You have free access to this content

    Current Version

    HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

    Suetonia C Palmer, Sankar D Navaneethan, Jonathan C Craig, David W Johnson, Vlado Perkovic, Jorgen Hegbrant and Giovanni FM Strippoli

    Version of Record online: 31 MAY 2014 | DOI: 10.1002/14651858.CD007784.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

    Sankar D Navaneethan, Francesca Pansini, Vlado Perkovic, Carlo Manno, Fabio Pellegrini, David W Johnson, Jonathan C Craig and Giovanni FM Strippoli

    Version of Record online: 15 APR 2009 | DOI: 10.1002/14651858.CD007784